In medullary thyroid carcinoma (MTC), CDK5, p35 and p25 are highly expressed, and CDK5 promotes tumorigenesis and tumor progression via down-regulating its downstream target, Retinoblastoma gene (Rb) [20]. This evidence concerns the gene CDK5R1 and neoplasm.